Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 47.58x is 851% above its 4-year average of -6.34x, near the high end of its 4-year range (-19.06x–53.17x).
1902.83% above its 12-month average of 2.38x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): 53.17x.
INTEREST COVERAGE RATIO
47.58x
INTEREST COVERAGE RATIO AVG TTM
2.38x
INTEREST COVERAGE RATIO AVG 3Y
-6.49x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1902.83%
CURRENT VS 3Y AVG
+832.66%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.14x
median of 503 covered companies
CURRENT VS SECTOR MEDIAN
+874.92%
vs the sector median at left
Elutia Inc
Market Cap
$34.04M
Interest Coverage Ratio
47.58x
TTM Avg
2.38x
3Y Avg
-6.49x
5Y Avg
N/A
Market Cap
$34.66M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.32M
Interest Coverage Ratio
-0.75x
TTM Avg
0.33x
3Y Avg
0.47x
5Y Avg
0.65x
Market Cap
$35.23M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.25M
Interest Coverage Ratio
N/A
TTM Avg
8.27x
3Y Avg
8.27x
5Y Avg
8.27x
Market Cap
$35.76M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$33.17M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.92M
Interest Coverage Ratio
-10.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.26M
Interest Coverage Ratio
1146.00x
TTM Avg
576.00x
3Y Avg
576.00x
5Y Avg
576.00x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $34.04M | 47.58x | 2.38x | -6.49x | N/A |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.66M | N/A | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $33.32M | -0.75x | 0.33x | 0.47x | 0.65x |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.23M | -735.69x | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.25M | N/A | 8.27x | 8.27x | 8.27x |
| DocGo Inc. (DCGO)vs › | $35.76M | -87.92x | 13.24x | 16.68x | 16.68x |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.17M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.92M | -10.67x | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $36.26M | 1146.00x | 576.00x | 576.00x | 576.00x |
| Rockwell Medical, Inc. (RMTI)vs › | $32.68M | -4.17x | 0.48x | 0.48x | 0.48x |
Interest Coverage
47.6x
Debt/Equity
0.69
Current Ratio
1.77
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | 53.17x |
| 2025-12-31 | 1.51x |
| 2025-09-30 | -16.43x |
| 2025-06-30 | -19.06x |
| 2025-03-31 | -7.30x |
| 2024-12-31 | -7.88x |
| 2024-09-30 | -9.06x |
| 2024-06-30 | -6.72x |
| 2024-03-31 | -6.46x |
| 2023-12-31 | -5.63x |
| 2023-09-30 | -5.09x |
| 2023-06-30 | -4.48x |
| 2023-03-31 | -5.83x |
| 2022-12-31 | -5.66x |
| 2022-09-30 | -7.19x |
| 2022-06-30 | -6.80x |
| 2022-03-31 | -5.70x |
| 2021-12-31 | -6.02x |
| 2021-09-30 | -5.25x |
